Home > > Global Osteoarthritis Therapeutics Market Report
TABLE OF CONTENTS CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.1. OVERVIEW 3.2. KNEE OSTEOARTHRITIS 3.2.1. KNEE OSTEOARTHRITIS MARKET, BY REGION 3.2.1.1. NORTH AMERICA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 3.2.1.2. EUROPE KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 3.2.1.3. ASIA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 3.2.1.4. MIDDLE EAST & AFRICA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 3.3. HIP OSTEOARTHRITIS 3.3.1. HIP OSTEOARTHRITIS MARKET, BY REGION 3.3.1.1. NORTH AMERICA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 3.3.1.2. EUROPE HIP OSTEOARTHRITIS MARKET, BY COUNTRY 3.3.1.3. ASIA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 3.3.1.4. MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 3.4. HAND OSTEOARTHRITIS 3.4.1. HAND OSTEOARTHRITIS MARKET, BY REGION 3.4.1.1. NORTH AMERICA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 3.4.1.2. EUROPE HAND OSTEOARTHRITIS MARKET, BY COUNTRY 3.4.1.3. ASIA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 3.4.1.4. MIDDLE EAST & AFRICA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 3.5. SMALL JOINT OSTEOARTHRITIS 3.5.1. SMALL JOINT OSTEOARTHRITIS MARKET, BY REGION 3.5.1.1. NORTH AMERICA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 3.5.1.2. EUROPE SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 3.5.1.3. ASIA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 3.5.1.4. MIDDLE EAST & AFRICA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY CHAPTER 4: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 4.1. OVERVIEW 4.2. VISCOSUPPLEMENTATION AGENTS 4.2.1. VISCOSUPPLEMENTATION AGENTS MARKET, BY REGION 4.2.1.1. NORTH AMERICA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 4.2.1.2. EUROPE VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 4.2.1.3. ASIA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 4.3. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 4.3.1. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY REGION 4.3.1.1. NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 4.3.1.2. EUROPE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 4.3.1.3. ASIA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 4.4. ANALGESICS 4.4.1. ANALGESICS MARKET, BY REGION 4.4.1.1. NORTH AMERICA ANALGESICS MARKET, BY COUNTRY 4.4.1.2. EUROPE ANALGESICS MARKET, BY COUNTRY 4.4.1.3. ASIA ANALGESICS MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA ANALGESICS MARKET, BY COUNTRY 4.5. CORTICOSTEROIDS 4.5.1. CORTICOSTEROIDS MARKET, BY REGION 4.5.1.1. NORTH AMERICA CORTICOSTEROIDS MARKET, BY COUNTRY 4.5.1.2. EUROPE CORTICOSTEROIDS MARKET, BY COUNTRY 4.5.1.3. ASIA CORTICOSTEROIDS MARKET, BY COUNTRY 4.5.1.4. MIDDLE EAST & AFRICA CORTICOSTEROIDS MARKET, BY COUNTRY CHAPTER 5: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 5.1. OVERVIEW 5.2. PARENTERAL ROUTE 5.2.1. PARENTERAL ROUTE MARKET, BY REGION 5.2.1.1. NORTH AMERICA PARENTERAL ROUTE MARKET, BY COUNTRY 5.2.1.2. EUROPE PARENTERAL ROUTE MARKET, BY COUNTRY 5.2.1.3. ASIA PARENTERAL ROUTE MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA PARENTERAL ROUTE MARKET, BY COUNTRY 5.3. ORAL ROUTE 5.3.1. ORAL ROUTE MARKET, BY REGION 5.3.1.1. NORTH AMERICA ORAL ROUTE MARKET, BY COUNTRY 5.3.1.2. EUROPE ORAL ROUTE MARKET, BY COUNTRY 5.3.1.3. ASIA ORAL ROUTE MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA ORAL ROUTE MARKET, BY COUNTRY 5.4. TOPICAL ROUTE 5.4.1. TOPICAL ROUTE MARKET, BY REGION 5.4.1.1. NORTH AMERICA TOPICAL ROUTE MARKET, BY COUNTRY 5.4.1.2. EUROPE TOPICAL ROUTE MARKET, BY COUNTRY 5.4.1.3. ASIA TOPICAL ROUTE MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET, BY COUNTRY CHAPTER 6: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY REGION 6.1. OVERVIEW 6.2. NORTH AMERICA 6.2.1. NORTH AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.2.2. NORTH AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.2.3. NORTH AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.2.4. NORTH AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY COUNTRY 6.2.4.1. US 6.2.4.1.1. US OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.2.4.1.2. US OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.2.4.1.3. US OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.2.4.2. CANADA 6.2.4.2.1. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.2.4.2.2. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.2.4.2.3. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.3. EUROPE 6.3.1. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.3.2. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.3.3. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.3.4. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET, BY COUNTRY 6.3.4.1. GERMANY 6.3.4.1.1. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.3.4.1.2. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.3.4.1.3. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.3.4.2. UK 6.3.4.2.1. UK OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.3.4.2.2. UK OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.3.4.2.3. UK OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.3.4.3. FRANCE 6.3.4.3.1. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.3.4.3.2. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.3.4.3.3. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.3.4.4. ITALY 6.3.4.4.1. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.3.4.4.2. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.3.4.4.3. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.3.4.5. SPAIN 6.3.4.5.1. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.3.4.5.2. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.3.4.5.3. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.3.4.6. ROE 6.3.4.6.1. ROE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.3.4.6.2. ROE OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.3.4.6.3. ROE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.4. ASIA 6.4.1. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.4.2. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.4.3. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.4.4. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY COUNTRY 6.4.4.1. JAPAN 6.4.4.1.1. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.4.4.1.2. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.4.4.1.3. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.4.4.2. CHINA 6.4.4.2.1. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.4.4.2.2. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.4.4.2.3. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.4.4.3. INDIA 6.4.4.3.1. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.4.4.3.2. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.4.4.3.3. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.4.4.4. AUSTRALIA 6.4.4.4.1. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.4.4.4.2. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.4.4.4.3. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.4.4.5. ROAPAC 6.4.4.5.1. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.4.4.5.2. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.4.4.5.3. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.5. MIDDLE EAST & AFRICA 6.5.1. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.5.2. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.5.3. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.5.4. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY COUNTRY 6.5.4.1. LATIN AMERICA 6.5.4.1.1. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.5.4.1.2. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.5.4.1.3. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.5.4.2. MEA 6.5.4.2.1. MEA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.5.4.2.2. MEA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.5.4.2.3. MEA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION TABLE 124. MEA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION)LIST OF TABLES TABLE 01. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 02. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 03. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 04. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 06. KNEE OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 07. NORTH AMERICA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 08. EUROPE KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 09. ASIA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. MIDDLE EAST & AFRICA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 11. HIP OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 12. NORTH AMERICA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 13. EUROPE HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 14. ASIA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 15. MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 16. HAND OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 17. NORTH AMERICA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 18. EUROPE HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 19. ASIA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 20. MIDDLE EAST & AFRICA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 21. SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 22. NORTH AMERICA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 23. EUROPE SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 24. ASIA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 25. MIDDLE EAST & AFRICA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 26. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 27. VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 28. NORTH AMERICA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 29. EUROPE VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 30. ASIA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 33. NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. EUROPE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 35. ASIA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. MIDDLE EAST & AFRICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. ANALGESICS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 38. NORTH AMERICA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 39. EUROPE ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. ASIA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. MIDDLE EAST & AFRICA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. CORTICOSTEROIDS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 43. NORTH AMERICA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 44. EUROPE CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. ASIA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. MIDDLE EAST & AFRICA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 48. PARENTERAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 49. NORTH AMERICA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 50. EUROPE PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 51. ASIA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. MIDDLE EAST & AFRICA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. ORAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 54. NORTH AMERICA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 55. EUROPE ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 56. ASIA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 57. MIDDLE EAST & AFRICA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 58. TOPICAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 59. NORTH AMERICA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 60. EUROPE TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 61. ASIA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 62. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 63. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 64. NORTH AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($MILLION) TABLE 65. NORTH AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($MILLION) TABLE 66. NORTH AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($MILLION) TABLE 67. NORTH AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 68. US OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 69. US OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 70. US OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 71. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 72. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 73. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 74. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($MILLION) TABLE 75. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($MILLION) TABLE 76. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($MILLION) TABLE 77. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 78. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 79. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 80. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 81. UK OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 82. UK OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 83. UK OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 84. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 85. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 86. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 87. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 88. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 89. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 90. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 91. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 92. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 93. ROE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 94. ROE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 95. ROE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 96. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($MILLION) TABLE 97. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($MILLION) TABLE 98. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($MILLION) TABLE 99. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 100. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 101. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 102. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 103. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 104. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 105. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 106. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 107. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 108. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 109. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 110. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 111. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 112. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 113. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 114. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 115. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($MILLION) TABLE 116. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($MILLION) TABLE 117. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($MILLION) TABLE 118. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 119. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 120. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 121. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 122. MEA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 123. MEA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 124. MEA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION)LIST OF FIGURES CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.1. OVERVIEW 3.2. KNEE OSTEOARTHRITIS 3.2.1. KNEE OSTEOARTHRITIS MARKET, BY REGION 3.2.1.1. NORTH AMERICA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 3.2.1.2. EUROPE KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 3.2.1.3. ASIA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 3.2.1.4. MIDDLE EAST & AFRICA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 3.3. HIP OSTEOARTHRITIS 3.3.1. HIP OSTEOARTHRITIS MARKET, BY REGION 3.3.1.1. NORTH AMERICA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 3.3.1.2. EUROPE HIP OSTEOARTHRITIS MARKET, BY COUNTRY 3.3.1.3. ASIA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 3.3.1.4. MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 3.4. HAND OSTEOARTHRITIS 3.4.1. HAND OSTEOARTHRITIS MARKET, BY REGION 3.4.1.1. NORTH AMERICA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 3.4.1.2. EUROPE HAND OSTEOARTHRITIS MARKET, BY COUNTRY 3.4.1.3. ASIA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 3.4.1.4. MIDDLE EAST & AFRICA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 3.5. SMALL JOINT OSTEOARTHRITIS 3.5.1. SMALL JOINT OSTEOARTHRITIS MARKET, BY REGION 3.5.1.1. NORTH AMERICA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 3.5.1.2. EUROPE SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 3.5.1.3. ASIA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 3.5.1.4. MIDDLE EAST & AFRICA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY CHAPTER 4: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 4.1. OVERVIEW 4.2. VISCOSUPPLEMENTATION AGENTS 4.2.1. VISCOSUPPLEMENTATION AGENTS MARKET, BY REGION 4.2.1.1. NORTH AMERICA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 4.2.1.2. EUROPE VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 4.2.1.3. ASIA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 4.3. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 4.3.1. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY REGION 4.3.1.1. NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 4.3.1.2. EUROPE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 4.3.1.3. ASIA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 4.4. ANALGESICS 4.4.1. ANALGESICS MARKET, BY REGION 4.4.1.1. NORTH AMERICA ANALGESICS MARKET, BY COUNTRY 4.4.1.2. EUROPE ANALGESICS MARKET, BY COUNTRY 4.4.1.3. ASIA ANALGESICS MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA ANALGESICS MARKET, BY COUNTRY 4.5. CORTICOSTEROIDS 4.5.1. CORTICOSTEROIDS MARKET, BY REGION 4.5.1.1. NORTH AMERICA CORTICOSTEROIDS MARKET, BY COUNTRY 4.5.1.2. EUROPE CORTICOSTEROIDS MARKET, BY COUNTRY 4.5.1.3. ASIA CORTICOSTEROIDS MARKET, BY COUNTRY 4.5.1.4. MIDDLE EAST & AFRICA CORTICOSTEROIDS MARKET, BY COUNTRY CHAPTER 5: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 5.1. OVERVIEW 5.2. PARENTERAL ROUTE 5.2.1. PARENTERAL ROUTE MARKET, BY REGION 5.2.1.1. NORTH AMERICA PARENTERAL ROUTE MARKET, BY COUNTRY 5.2.1.2. EUROPE PARENTERAL ROUTE MARKET, BY COUNTRY 5.2.1.3. ASIA PARENTERAL ROUTE MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA PARENTERAL ROUTE MARKET, BY COUNTRY 5.3. ORAL ROUTE 5.3.1. ORAL ROUTE MARKET, BY REGION 5.3.1.1. NORTH AMERICA ORAL ROUTE MARKET, BY COUNTRY 5.3.1.2. EUROPE ORAL ROUTE MARKET, BY COUNTRY 5.3.1.3. ASIA ORAL ROUTE MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA ORAL ROUTE MARKET, BY COUNTRY 5.4. TOPICAL ROUTE 5.4.1. TOPICAL ROUTE MARKET, BY REGION 5.4.1.1. NORTH AMERICA TOPICAL ROUTE MARKET, BY COUNTRY 5.4.1.2. EUROPE TOPICAL ROUTE MARKET, BY COUNTRY 5.4.1.3. ASIA TOPICAL ROUTE MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET, BY COUNTRY CHAPTER 6: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY REGION 6.1. OVERVIEW 6.2. NORTH AMERICA 6.2.1. NORTH AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.2.2. NORTH AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.2.3. NORTH AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.2.4. NORTH AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY COUNTRY 6.2.4.1. US 6.2.4.1.1. US OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.2.4.1.2. US OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.2.4.1.3. US OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.2.4.2. CANADA 6.2.4.2.1. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.2.4.2.2. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.2.4.2.3. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.3. EUROPE 6.3.1. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.3.2. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.3.3. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.3.4. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET, BY COUNTRY 6.3.4.1. GERMANY 6.3.4.1.1. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.3.4.1.2. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.3.4.1.3. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.3.4.2. UK 6.3.4.2.1. UK OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.3.4.2.2. UK OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.3.4.2.3. UK OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.3.4.3. FRANCE 6.3.4.3.1. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.3.4.3.2. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.3.4.3.3. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.3.4.4. ITALY 6.3.4.4.1. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.3.4.4.2. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.3.4.4.3. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.3.4.5. SPAIN 6.3.4.5.1. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.3.4.5.2. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.3.4.5.3. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.3.4.6. ROE 6.3.4.6.1. ROE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.3.4.6.2. ROE OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.3.4.6.3. ROE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.4. ASIA 6.4.1. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.4.2. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.4.3. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.4.4. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY COUNTRY 6.4.4.1. JAPAN 6.4.4.1.1. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.4.4.1.2. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.4.4.1.3. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.4.4.2. CHINA 6.4.4.2.1. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.4.4.2.2. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.4.4.2.3. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.4.4.3. INDIA 6.4.4.3.1. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.4.4.3.2. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.4.4.3.3. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.4.4.4. AUSTRALIA 6.4.4.4.1. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.4.4.4.2. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.4.4.4.3. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.4.4.5. ROAPAC 6.4.4.5.1. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.4.4.5.2. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.4.4.5.3. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.5. MIDDLE EAST & AFRICA 6.5.1. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.5.2. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.5.3. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.5.4. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY COUNTRY 6.5.4.1. LATIN AMERICA 6.5.4.1.1. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.5.4.1.2. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.5.4.1.3. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.5.4.2. MEA 6.5.4.2.1. MEA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 6.5.4.2.2. MEA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 6.5.4.2.3. MEA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION TABLE 01. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 02. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 03. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 04. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 06. KNEE OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 07. NORTH AMERICA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 08. EUROPE KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 09. ASIA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. MIDDLE EAST & AFRICA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 11. HIP OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 12. NORTH AMERICA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 13. EUROPE HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 14. ASIA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 15. MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 16. HAND OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 17. NORTH AMERICA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 18. EUROPE HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 19. ASIA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 20. MIDDLE EAST & AFRICA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 21. SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 22. NORTH AMERICA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 23. EUROPE SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 24. ASIA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 25. MIDDLE EAST & AFRICA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 26. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 27. VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 28. NORTH AMERICA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 29. EUROPE VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 30. ASIA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 33. NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. EUROPE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 35. ASIA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. MIDDLE EAST & AFRICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. ANALGESICS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 38. NORTH AMERICA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 39. EUROPE ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. ASIA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. MIDDLE EAST & AFRICA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($